PMID: 6402450Mar 1, 1983Paper

Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats

Hypertension
M A BayorhI J Kopin

Abstract

In rats between the ages of 4 and 12 or 14 weeks, repeated daily subcutaneous administration of arachidonate (AA) at a dose of 50 or 200 mg/kg significantly retarded the development of hypertension in spontaneously hypertensive rats (SHR) but did not alter the normal age-related increase in blood pressures (BP) of normotensive (WKY) rats. Heart rates (HR) and plasma levels of norepinephrine (NE), but not epinephrine, were lower in AA-treated SHR than in saline-treated animals. AA-treated SHR and WKY gained less weight than the saline-treated controls. In pithed AA-treated SHR, stimulation of the sympathetic outflow (50 V, for 1 minute at 0.3 or 3.0 Hz) and intravenous administration of NE (0.3 or 3.0 g/kg) evoked smaller pressor responses than in saline-treated controls, but the stimulation-evoked increases in plasma catecholamines were unchanged by AA treatment. These results indicated that, in SHR, chronic AA treatment reduces BP by mechanisms that do not directly affect NE release from sympathetic nerves. There appears to be both reduced central nervous system activation of the sympathetic outflow and diminished responses to peripheral sympathetic stimulation and exogeneous NE which may be secondary to the reduced vascular h...Continue Reading

References

Aug 1, 1976·Biulleten' eksperimental'noĭ biologii i meditsiny·V P KulaginaM G Udel'nov
Jan 1, 1977·Annual Review of Pharmacology and Toxicology·P Hedqvist
May 18, 1978·The New England Journal of Medicine·P Needleman, G Kaley
Oct 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·T H HintzeG Kaley
Jan 1, 1978·Biochemical Pharmacology·Y NaraW Lovenberg
Apr 1, 1975·Chemico-biological Interactions·H Laborit, N Valette
Jun 1, 1973·Physiology & Behavior·C A BaileH L Jacobs
Jan 1, 1970·Naunyn-Schmiedebergs Archiv Für Pharmakologie·G Haeusler, W Haefely
Jul 1, 1973·The American Journal of Physiology·J B Gross, F C Barter
May 1, 1974·The American Journal of Physiology·J W StrandhoyF G Knox
Jul 1, 1970·Acta Physiologica Scandinavica·B FolkowL Weiss
Oct 1, 1980·Prostaglandins and Medicine·G FeinbergA M Lefer
Jul 10, 1981·European Journal of Pharmacology·R L ZerbeI J Kopin
Mar 1, 1981·Brain Research Bulletin·G FeuersteinD M Jacobowitz

❮ Previous
Next ❯

Citations

Jul 1, 1985·Peptides·T L O'DonohueD A DiMaggio
Feb 1, 1986·Prostaglandins, Leukotrienes, and Medicine·P Hoffmann
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·D EzraG Feuerstein
Jan 1, 1996·Clinical and Experimental Hypertension : CHE·M A BayorhV M Chenault
Jul 26, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Dongling LiuYingbi Zhou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.